IP
CELG

Isthmus Partners’s Celgene Corp CELG Stock Holding History

Isthmus Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-85,454
Closed -$8.49M – 145
2019
Q3 		$8.49M Sell
85,454
-550
-0.6% -$52.3K 2.01% 13
2019
Q2 		$7.95M Buy
+86,004
New +$8.17M 1.9% 17
2019
Q1 		– Sell
-55,960
Closed -$3.59M – 208
2018
Q4 		$3.59M Sell
55,960
-3,891
-7% -$287K 1.08% 39
2018
Q3 		$5.36M Buy
59,851
+3,130
+6% +$277K 1.35% 40
2018
Q2 		$4.5M Buy
56,721
+1,999
+4% +$166K 1.17% 43
2018
Q1 		$4.88M Buy
54,722
+2,573
+5% +$247K 1.32% 43
2017
Q4 		$5.44M Buy
52,149
+1,821
+4% +$205K 1.48% 39
2017
Q3 		$7.34M Sell
50,328
-1,761
-3% -$240K 2.06% 10
2017
Q2 		$6.76M Sell
52,089
-2,235
-4% -$274K 1.98% 15
2017
Q1 		$6.76M Sell
54,324
-441
-0.8% -$52.8K 1.98% 15
2016
Q4 		$6.34M Sell
54,765
-33
-0.1% -$3.67K 1.91% 19
2016
Q3 		$5.49M Sell
54,798
-1,277
-2% -$138K 1.74% 30
2016
Q2 		$5.53M Sell
56,075
-772
-1% -$79.9K 1.82% 28
2016
Q1 		$5.69M Buy
56,847
+104
+0.2% +$10.7K 1.9% 23
2015
Q4 		$6.8M Sell
56,743
-156
-0.3% -$18K 2.37% 5
2015
Q3 		$6.16M Sell
56,899
-2,709
-5% -$336K 2.26% 6
2015
Q2 		$6.9M Sell
59,608
-3,409
-5% -$390K 2.28% 5
2015
Q1 		$7.26M Buy
63,017
+551
+0.9% +$65.8K 2.46% 1
2014
Q4 		$6.99M Buy
+62,466
New +$6.59M 2.38% 3

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Isthmus Partners's CELG Position: Q4 2019 in Review

Isthmus Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 85,454 shares — an estimated $8.49M sold.

Isthmus Partners first reported a position in CELG in Q4 2014 and held it in 19 quarters. The position peaked at $8.49M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Isthmus Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Isthmus Partners sold 85,454 Celgene Corp shares in Q4 2019, an estimated $8.49M.
  • Isthmus Partners first reported a position in Celgene Corp in Q4 2014 and held it in 19 quarters.
  • Isthmus Partners's Celgene Corp position peaked at $8.49M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Isthmus Partners's 13F filing for Q4 2019, filed 7 Feb 2020.